HIV care providers applaud Congress' extension of Ryan White programOctober 22, 2009Arlington, Va. - Medical providers on the front lines of HIV care applaud the U.S. Congress for extending the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care. The HIV Medicine Association (HIVMA) and the Ryan White Medical Providers Coalition (RWMPC) are pleased with Congress' four-year extension of this critical safety net and urge President Obama to quickly sign this important legislation. "As HIV clinicians and researchers, many of whom have been providing HIV care since the mid-1980s, it is gratifying to see so many of our patients benefiting from the current treatment approaches, especially compared with the heartbreaking patient outcomes we saw earlier in the pandemic," said Michael S. Saag, MD, FIDSA, HIVMA chair-elect. "These remarkable outcomes simply would not be possible without support from the Ryan White Program. We thank Congress for extending this vital program for four years, and we call on the president to quickly sign this legislation to ensure that our patients have access to the care they need." The Ryan White HIV/AIDS Treatment Extension Act of 2009 would authorize a 5 percent annual increase in funding for the program, which funds medical care and other services for individuals who otherwise would likely go without care. With more than 50,000 new cases of HIV infection in this country every year, HIVMA and RWMPC urge lawmakers to increase Ryan White funding annually by at least this authorized amount, if not more, during the next four years to help address the growing need for treatment. "Even before the current recession hit, many HIV clinics and providers were struggling to maintain the level of services that have made them so effective at delivering lifesaving care to their patients," said Kathleen Clanon, MD, RWMPC co-chair. "As the strains on our health care system grow, HIV caseloads rise, and state HIV programs are threatened by additional budget cuts, adequate funding increases for the Ryan White Program will be critical to ensuring that patients continue to receive the multidisciplinary care they need, even when they cannot afford it." With lawmakers finalizing health care reform legislation, the extension of the Ryan White Program is vital to ensuring there are no gaps in coverage or access to care for those living with HIV/AIDS as reforms are implemented nationwide. Additionally, health reform offers a unique opportunity to increase support for the medical home model of care provided by Ryan White programs and to integrate these programs into the reformed health care system. "Ryan White programs, at HIV clinics around the country, are models for delivering high-quality, cost-effective care to people with chronic conditions," said J. Kevin Carmichael, MD, RWMPC co-chair. "This patient-centered approach, known as the medical home model, treats the whole person by providing a range of services that HIV/AIDS patients need to stay healthy. It's critical to keeping people with HIV in treatment and addressing their complex health care needs." Treatment advances have transformed HIV infection from a death sentence to a chronic condition for many patients, but only for those with ongoing access to medical care. "Funding through Ryan White has allowed HIV clinics across the country to develop model programs to deliver this comprehensive and coordinated care for more than a decade," said Dr. Saag. "We could not do the work we do every day without this support, and this four-year extension will help ensure that it continues." Infectious Diseases Society of America |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Indiana U. at APHA: Studies about why men and women use lubricants during sex An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||